Lethal Prion Protein Causes Neuronal Death
|
By LabMedica International staff writers Posted on 01 Mar 2012 |
A single prion protein that is at least 10 times more lethal than larger prion species has been identified that causes disease similar to mad cow disease.
The toxic form of abnormal prion protein, known as TPrP, triggered various forms of neuronal damage, including molecular signatures very similar to that seen in the brains of prion-infected animal with bovine spongiform encephalopathy (BSE).
Scientists at the Scripps Research Institute (Jupiter, FL, USA) found that the most lethal form of prion protein was a specific structure known as alpha-helical. This toxic single molecule or "monomer" tests the existing theory that neuronal damage is associated with the toxicity of prion protein aggregates called "oligomers."
A variety of techniques was used to provide fresh insights into prion diseases, such as BSE and a rare human form Creutzfeldt-Jakob disease. Furthermore, it opened the possibility that associated neurotoxic proteins may play a role in neurodegenerative disorders, such as Parkinson, and Alzheimer's diseases.
In prion disease, proteinaceous infectious particles (infectious prions), believed to be made up only of protein, are able to reproduce, even though they lack ribonucleic acid (RNA) and DNA. Usually, mammalian cells generate cellular prion protein (PrP), when infected with a prion disease; the abnormal protein converts the normal host prion protein into its disease form.
Corinne Lasmézas, PhD, the lead author and a professor at Scripps, said "By identifying a single molecule as the most toxic species of prion proteins, we've opened a new chapter in understanding how prion-induced neurodegeneration occurs. We didn't think we would find neuronal death from this toxic monomer so close to what normally happens in the disease state. Now we have a powerful tool to explore the mechanisms of neurodegeneration."
Professor Lasmézas added, "Until now, it was thought that oligomers of proteins are toxic in all these disease. Since we found for the first time that an abnormally folded monomer is highly toxic, it opens up the possibility that this might be true also for some other protein misfolding diseases as well." The study was published on February 7, 2012 in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).
Related Links:
Scripps Research Institute
The toxic form of abnormal prion protein, known as TPrP, triggered various forms of neuronal damage, including molecular signatures very similar to that seen in the brains of prion-infected animal with bovine spongiform encephalopathy (BSE).
Scientists at the Scripps Research Institute (Jupiter, FL, USA) found that the most lethal form of prion protein was a specific structure known as alpha-helical. This toxic single molecule or "monomer" tests the existing theory that neuronal damage is associated with the toxicity of prion protein aggregates called "oligomers."
A variety of techniques was used to provide fresh insights into prion diseases, such as BSE and a rare human form Creutzfeldt-Jakob disease. Furthermore, it opened the possibility that associated neurotoxic proteins may play a role in neurodegenerative disorders, such as Parkinson, and Alzheimer's diseases.
In prion disease, proteinaceous infectious particles (infectious prions), believed to be made up only of protein, are able to reproduce, even though they lack ribonucleic acid (RNA) and DNA. Usually, mammalian cells generate cellular prion protein (PrP), when infected with a prion disease; the abnormal protein converts the normal host prion protein into its disease form.
Corinne Lasmézas, PhD, the lead author and a professor at Scripps, said "By identifying a single molecule as the most toxic species of prion proteins, we've opened a new chapter in understanding how prion-induced neurodegeneration occurs. We didn't think we would find neuronal death from this toxic monomer so close to what normally happens in the disease state. Now we have a powerful tool to explore the mechanisms of neurodegeneration."
Professor Lasmézas added, "Until now, it was thought that oligomers of proteins are toxic in all these disease. Since we found for the first time that an abnormally folded monomer is highly toxic, it opens up the possibility that this might be true also for some other protein misfolding diseases as well." The study was published on February 7, 2012 in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).
Related Links:
Scripps Research Institute
Latest Microbiology News
- Breath Analysis Approach Offers Rapid Detection of Bacterial Infection
- Study Highlights Accuracy Gaps in Consumer Gut Microbiome Kits
- WHO Recommends Near POC Tests, Tongue Swabs and Sputum Pooling for TB Diagnosis
- New Imaging Approach Could Help Predict Dangerous Gut Infection
- Rapid Sequencing Could Transform Tuberculosis Care
- Blood-Based Viral Signature Identified in Crohn’s Disease
- Hidden Gut Viruses Linked to Colorectal Cancer Risk
- Three-Test Panel Launched for Detection of Liver Fluke Infections
- Rapid Test Promises Faster Answers for Drug-Resistant Infections
- CRISPR-Based Technology Neutralizes Antibiotic-Resistant Bacteria
- Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
- AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
- New Test Measures How Effectively Antibiotics Kill Bacteria
- New Antimicrobial Stewardship Standards for TB Care to Optimize Diagnostics
- New UTI Diagnosis Method Delivers Antibiotic Resistance Results 24 Hours Earlier
- Breakthroughs in Microbial Analysis to Enhance Disease Prediction
Channels
Clinical Chemistry
view channel
Blood-Based Screening Test Targets Early Detection of Colorectal Cancer
Colorectal cancer (CRC) is a leading cause of cancer-related death worldwide, with more than 60% of cases still diagnosed at a late stage. Uptake of existing screening tools remains suboptimal,... Read more
Automated NfL Assay Supports Monitoring of Neurological Disorders
Neuroaxonal injury occurs across a wide range of neurological disorders and remains difficult to monitor noninvasively over time. Blood-based measurement of neurofilament light chain (NfL) provides a biologically... Read moreMolecular Diagnostics
view channel
Plasma ctDNA Testing Predicts Breast Cancer Recurrence After Neoadjuvant Therapy
Accurate identification of breast cancer patients at risk of relapse after pre-surgery treatment is central to guiding adjuvant decisions, particularly in aggressive disease. Circulating fragments of tumor... Read more
New Respiratory Panel Expands Pathogen Detection to 25 Targets
Respiratory infections often present with overlapping symptoms, complicating differential diagnosis in acute and community settings. The stakes are higher for older adults, young children, and people with... Read moreHematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read moreImmunology
view channel
Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
Bladder cancer remains a prevalent malignancy with variable responses to immune checkpoint inhibitors. Clinicians often observe elevated C-reactive protein and interleukin-6 in affected patients, yet the... Read more
Microfluidic Chip Detects Cancer Recurrence from Immune Response Signals
Early identification of treatment response and relapse remains a major challenge in solid tumors, where minimal residual disease is difficult to detect with routine imaging and blood tests.... Read morePathology
view channel
Biopsy-Based Gene Test Predicts Recurrence Risk in Lung Adenocarcinoma
Lung cancer is the leading cause of cancer death, killing more people in the United States than breast, prostate, and colon cancers combined. In lung adenocarcinoma (LUAD), tumors that invade nearby blood... Read more
AI-Powered Tool to Transform Dermatopathology Workflow
Skin cancer accounts for the largest number of cancer diagnoses in the United States, placing sustained pressure on pathology services. Diagnostic interpretation can be variable for challenging melanocytic... Read moreTechnology
view channel
Online Tool Supports Family Screening for Inherited Cancer Risk
Genetic test results in oncology often have implications for relatives who may share inherited cancer risk. Many health systems lack structured processes to help patients alert family members, limiting... Read more
Portable Breath Sensor Detects Pneumonia Biomarkers in Minutes
Pneumonia is commonly confirmed with chest X-rays or laboratory assays that can take hours, delaying clinical decisions in acute and outpatient settings. Breath-based diagnostics promise faster answers... Read moreIndustry
view channel
Integrated DNA Technologies Expands into Clinical Diagnostics
Integrated DNA Technologies (IDT; Coralville, Iowa, USA) has announced the launch of Archer FUSIONPlex-HT Dx and VARIANTPlex-HT Dx. This launch marks the company’s first in vitro diagnostic (IVD) offerings... Read more








